Brief: Actuate Therapeutics Enters Stock Purchase Agreement With B. Riley Principal Capital Ii, Llc
28/03/2025 12:40
March 28 (Reuters) - Actuate Therapeutics Inc ACTU.O: ACTUATE THERAPEUTICS INC - ENTERS STOCK PURCHASE AGREEMENT WITH B. RILEY PRINCIPAL CAPITAL II, LLC - SEC FILING ACTUATE THERAPEUTICS INC - HAVE THE RIGHT TO SELL UP TO $50 MILLION NEWLY ISSUED SHARES - SEC FILING Further company coverage: ACTU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Actuate Therapeutics
See all newsHealth Rounds: Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
Brief: Actuate Therapeutics Announces Plans To Expand Clinical Pipeline, Advancing Elraglusib Tablet Into A Phase 1/2 Clinical Program In Refractory Cancers
Brief: Actuate Therapeutics Inc - Reports Positive Phase 2 Trial Data For Elraglusib - SEC Filing
Brief: Actuate Therapeutics Announces Positive Patient Outcomes From Phase 1 Trial
Brief: Actuate Therapeutics Inc - Enters At The Market Issuance Sales Agreement With B. Riley And Craig-Hallum - SEC Filing